TY - JOUR
T1 - Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide
AU - Zhang, Lemeng
AU - Cardinal, Jon S.
AU - Bahar, Runalia
AU - Evankovich, John
AU - Huang, Hai
AU - Nace, Gary
AU - Billiar, Timothy R.
AU - Rosengart, Matthew R.
AU - Pan, Pinhua
AU - Tsung, Allan
N1 - Funding Information:
Financial support was received by The Howard Hughes Medical Institute Physician-Scientist Award (A Tsung) and by the American College of Sur geons Faculty Research Fellowship (A Tsung).
PY - 2012/2
Y1 - 2012/2
N2 - The pathogenesis of sepsis is complex and, unfortunately, poorly understood. The cellular process of autophagy is believed to play a protective role in sepsis; however, the mechanisms responsible for its regulation in this setting are ill defined. In the present study, interferon regulatory factor 1 (IRF-1) was found to regulate the autophagic response in lipopolysaccharide (LPS)-stimulated macrophages. In vivo, tissue macrophages obtained from LPS-stimulated IRF-1 knockout (KO) mice demonstrated increased autophagy and decreased apoptosis compared to those isolated from IRF-1 wild-type (WT) mice. In vitro, LPS-stimulated peritoneal macrophages obtained from IRF-1 KO mice experienced increased autophagy and decreased apoptosis. IRF-1 mediates the inhibition of autophagy by modulating the activation of the mammalian target of rapamycin (mTOR). LPS induced the activation of mTOR in WT peritoneal macrophages, but not in IRF-1 KO macrophages. In contrast, overexpression of IRF-1 alone increased the activation of mTOR and consequently decreased autophagic flux. Furthermore, the inhibitory effects of IRF-1 mTOR activity were mediated by nitric oxide (NO). Therefore, we propose a novel role for IRF-1 and NO in the regulation of macrophage autophagy during LPS stimulation in which IRF-1/NO inhibits autophagy through mTOR activation.
AB - The pathogenesis of sepsis is complex and, unfortunately, poorly understood. The cellular process of autophagy is believed to play a protective role in sepsis; however, the mechanisms responsible for its regulation in this setting are ill defined. In the present study, interferon regulatory factor 1 (IRF-1) was found to regulate the autophagic response in lipopolysaccharide (LPS)-stimulated macrophages. In vivo, tissue macrophages obtained from LPS-stimulated IRF-1 knockout (KO) mice demonstrated increased autophagy and decreased apoptosis compared to those isolated from IRF-1 wild-type (WT) mice. In vitro, LPS-stimulated peritoneal macrophages obtained from IRF-1 KO mice experienced increased autophagy and decreased apoptosis. IRF-1 mediates the inhibition of autophagy by modulating the activation of the mammalian target of rapamycin (mTOR). LPS induced the activation of mTOR in WT peritoneal macrophages, but not in IRF-1 KO macrophages. In contrast, overexpression of IRF-1 alone increased the activation of mTOR and consequently decreased autophagic flux. Furthermore, the inhibitory effects of IRF-1 mTOR activity were mediated by nitric oxide (NO). Therefore, we propose a novel role for IRF-1 and NO in the regulation of macrophage autophagy during LPS stimulation in which IRF-1/NO inhibits autophagy through mTOR activation.
UR - http://www.scopus.com/inward/record.url?scp=84859074254&partnerID=8YFLogxK
U2 - 10.2119/molmed.2011.00282
DO - 10.2119/molmed.2011.00282
M3 - Article
C2 - 22105605
AN - SCOPUS:84859074254
SN - 1076-1551
VL - 18
SP - 201
EP - 208
JO - Molecular Medicine
JF - Molecular Medicine
IS - 2
ER -